newsfilter
← Latest News
GlobeNewswire·

Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA

FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the official...